{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:46:41Z","timestamp":1775051201376,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00105-024-05331-w","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T14:02:15Z","timestamp":1718028135000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relevante Hautmanifestationen als Hinweis f\u00fcr angeborene Immundefekte","Relevant cutaneous manifestations as indications for inborn errors of immunity"],"prefix":"10.1007","volume":"75","author":[{"given":"Leonie","family":"Frommherz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Ak\u00e7etin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Giehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"5","key":"5331_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","volume":"71","author":"GJ Arason","year":"2010","unstructured":"Arason\u00a0GJ, Jorgensen\u00a0GH, Ludviksson\u00a0BR (2010) Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol 71(5):317\u2013328","journal-title":"Scand J Immunol"},{"issue":"8","key":"5331_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard\u00a0C, Al-Herz\u00a0W, Bousfiha\u00a0A, Casanova\u00a0JL, Chatila\u00a0T, Conley\u00a0ME et\u00a0al (2015) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J\u00a0Clin Immunol 35(8):696\u2013726","journal-title":"J Clin Immunol"},{"key":"5331_CR3","first-page":"1","volume-title":"Prim\u00e4re Immundefekte \u2013 Warnzeichen und Algorithmen zur Diagnosefindung","author":"UBB Baumann","year":"2010","unstructured":"Baumann\u00a0UBB, v. Bernuth\u00a0H, Friedrich\u00a0W, Linde\u00a0R, Niehues\u00a0T, Renner\u00a0E, Sch\u00f6ndorf\u00a0I, Schulze\u00a0I, Wahn\u00a0V et\u00a0al (2010) Prim\u00e4re Immundefekte \u2013 Warnzeichen und Algorithmen zur Diagnosefindung, 1.\u00a0Aufl. Bd. D\u201128323. UNI-MED Verlag AG, Bremen, S\u00a01","edition":"1"},{"key":"5331_CR4","unstructured":"(2017) Immundefekte SkLp. https:\/\/register.awmf.org\/assets\/guidelines\/112-001l_S2k_Primaere_Immundefekte_PID_2017-11_abgelaufen.pdf"},{"key":"5331_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","volume":"7","author":"D Buchbinder","year":"2014","unstructured":"Buchbinder\u00a0D, Nugent\u00a0DJ, Fillipovich\u00a0AH (2014) Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet 7:55\u201366","journal-title":"Appl Clin Genet"},{"issue":"3\u20134","key":"5331_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1155\/2010\/580197","volume":"29","author":"AF Freeman","year":"2010","unstructured":"Freeman\u00a0AF, Holland\u00a0SM (2010) Clinical manifestations of hyper IgE syndromes. Dis Markers 29(3\u20134):123\u2013130","journal-title":"Dis Markers"},{"issue":"16","key":"5331_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland\u00a0SM, DeLeo\u00a0FR, Elloumi\u00a0HZ, Hsu\u00a0AP, Uzel\u00a0G, Brodsky\u00a0N et\u00a0al (2007) STAT3 mutations in the hyper-IgE syndrome. N\u00a0Engl J Med 357(16):1608\u20131619","journal-title":"N Engl J Med"},{"issue":"4","key":"5331_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.alit.2021.07.007","volume":"70","author":"Y Minegishi","year":"2021","unstructured":"Minegishi\u00a0Y (2021) Hyper-IgE syndrome, 2021 update. Allergol Int 70(4):407\u2013414","journal-title":"Allergol Int"},{"issue":"4","key":"5331_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","volume":"97","author":"T Al-Shaikhly","year":"2019","unstructured":"Al-Shaikhly\u00a0T, Ochs\u00a0HD (2019) Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol 97(4):368\u2013379","journal-title":"Immunol Cell Biol"},{"issue":"7115","key":"5331_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud\u00a0S, Fondaneche\u00a0MC, Lambert\u00a0N, Pasquier\u00a0B, Mateo\u00a0V, Soulas\u00a0P et\u00a0al (2006) XIAP deficiency in humans causes an X\u2011linked lymphoproliferative syndrome. Nature 444(7115):110\u2013114","journal-title":"Nature"},{"issue":"2","key":"5331_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","volume":"151","author":"CC Dvorak","year":"2023","unstructured":"Dvorak\u00a0CC, Haddad\u00a0E, Heimall\u00a0J, Dunn\u00a0E, Buckley\u00a0RH, Kohn\u00a0DB et\u00a0al (2023) The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J\u00a0Allergy Clin Immunol 151(2):539\u2013546","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"5331_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s100240010171","volume":"4","author":"I Scheimberg","year":"2001","unstructured":"Scheimberg\u00a0I, Hoeger\u00a0PH, Harper\u00a0JI, Lake\u00a0B, Malone\u00a0M (2001) Omenn\u2019s syndrome: differential diagnosis in infants with erythroderma and immunodeficiency. Pediatr Dev Pathol 4(3):237\u2013245","journal-title":"Pediatr Dev Pathol"},{"key":"5331_CR13","volume-title":"Epidermodysplasia Verruciformis","author":"DJ Myers","year":"2023","unstructured":"Myers\u00a0DJ, Kwan\u00a0E, Fillman\u00a0EP, Treasure Island (FL) ineligible companies, Disclosure: Eddie Kwan declares no relevant financial relationships with ineligible companies, Disclosure: Eric Fillman declares no relevant financial relationships with ineligible companies (2023) Epidermodysplasia Verruciformis. StatPearls"},{"key":"5331_CR14","volume-title":"GeneReviews((R))","author":"K Zhang","year":"1993","unstructured":"Zhang\u00a0K, Astigarraga\u00a0I, Bryceson\u00a0Y, Lehmberg\u00a0K, Machowicz\u00a0R, Marsh\u00a0R et\u00a0al (1993) Familial Hemophagocytic Lymphohistiocytosis. In: Adam\u00a0MP, Mirzaa\u00a0GM, Pagon\u00a0RA, Wallace\u00a0SE, Bean\u00a0LJH, Gripp\u00a0KW et\u00a0al (Hrsg) GeneReviews((R)). Seattle (WA)"},{"issue":"16","key":"5331_CR15","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna\u00a0SW, Marsh\u00a0RA (2020) Pediatric hemophagocytic lymphohistiocytosis. Blood 135(16):1332\u20131343","journal-title":"Blood"},{"issue":"6","key":"5331_CR16","doi-asserted-by":"publisher","first-page":"e13034","DOI":"10.1111\/sji.13034","volume":"93","author":"LM Castano-Jaramillo","year":"2021","unstructured":"Castano-Jaramillo\u00a0LM, Lugo-Reyes\u00a0SO, Cruz Munoz\u00a0ME, Scheffler-Mendoza\u00a0SC, Duran McKinster\u00a0C, Yamazaki-Nakashimada\u00a0MA et\u00a0al (2021) Diagnostic and therapeutic caveats in Griscelli syndrome. Scand J Immunol 93(6):e13034","journal-title":"Scand J Immunol"},{"key":"5331_CR17","volume-title":"GeneReviews((R))","author":"WJ Introne","year":"1993","unstructured":"Introne\u00a0WJ, Huizing\u00a0M, Malicdan\u00a0MCV, O\u2019Brien\u00a0KJ, Gahl\u00a0WA (1993) Hermansky-Pudlak Syndrome. In: Adam\u00a0MP, Mirzaa\u00a0GM, Pagon\u00a0RA, Wallace\u00a0SE, Bean\u00a0LJH, Gripp\u00a0KW et\u00a0al (Hrsg) GeneReviews((R)). Seattle (WA)"},{"key":"5331_CR18","volume-title":"GeneReviews((R))","author":"C Toro","year":"1993","unstructured":"Toro\u00a0C, Nicoli\u00a0ER, Malicdan\u00a0MC, Adams\u00a0DR, Introne\u00a0WJ (1993) Chediak-Higashi Syndrome. In: Adam\u00a0MP, Mirzaa\u00a0GM, Pagon\u00a0RA, Wallace\u00a0SE, Bean\u00a0LJH, Gripp\u00a0KW et\u00a0al (Hrsg) GeneReviews((R)). Seattle (WA)"},{"issue":"3","key":"5331_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar\u00a0P, Ranjouri\u00a0MR, Yazdani\u00a0R, Abolhassani\u00a0H, Aghamohammadi\u00a0A (2019) Ataxia-telangiectasia: A\u00a0review of clinical features and molecular pathology. Pediatr Allergy Immunol 30(3):277\u2013288","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"5331_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye\u00a0SG, Al-Herz\u00a0W, Bousfiha\u00a0A, Cunningham-Rundles\u00a0C, Franco\u00a0JL, Holland\u00a0SM et\u00a0al (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J\u00a0Clin Immunol 42(7):1473\u20131507","journal-title":"J Clin Immunol"},{"issue":"2","key":"5331_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","volume":"144","author":"DR Matson","year":"2020","unstructured":"Matson\u00a0DR, Yang\u00a0DT (2020) Autoimmune Lymphoproliferative Syndrome: An Overview. Arch Pathol Lab Med 144(2):245\u2013251","journal-title":"Arch Pathol Lab Med"},{"key":"5331_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","volume":"198","author":"R Yazdani","year":"2019","unstructured":"Yazdani\u00a0R, Fekrvand\u00a0S, Shahkarami\u00a0S, Azizi\u00a0G, Moazzami\u00a0B, Abolhassani\u00a0H et\u00a0al (2019) The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol 198:19\u201330","journal-title":"Clin Immunol"},{"key":"5331_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","volume":"181","author":"CM Biggs","year":"2017","unstructured":"Biggs\u00a0CM, Keles\u00a0S, Chatila\u00a0TA (2017) DOCK8 deficiency: Insights into pathophysiology, clinical features and management. Clin Immunol 181:75\u201382","journal-title":"Clin Immunol"},{"key":"5331_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/CCIDE.S76080","volume":"7","author":"B Sreeramulu","year":"2015","unstructured":"Sreeramulu\u00a0B, Shyam\u00a0ND, Ajay\u00a0P, Suman\u00a0P (2015) Papillon-Lefevre syndrome: clinical presentation and management options. Clin Cosmet Investig Dent 7:75\u201381","journal-title":"Clin Cosmet Investig Dent"},{"issue":"2","key":"5331_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1365-2249.2006.03138.x","volume":"145","author":"E de Vries","year":"2006","unstructured":"de Vries\u00a0E (2006) Clinical Working Party of the European Society for I. Patient-centred screening for primary immunodeficiency: a\u00a0multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 145(2):204\u2013214","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"5331_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ng.3304","volume":"47","author":"JC Taylor","year":"2015","unstructured":"Taylor\u00a0JC, Martin\u00a0HC, Lise\u00a0S, Broxholme\u00a0J, Cazier\u00a0JB, Rimmer\u00a0A et\u00a0al (2015) Factors influencing success of clinical genome sequencing across a\u00a0broad spectrum of disorders. Nat Genet 47(7):717\u2013726","journal-title":"Nat Genet"},{"key":"5331_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","volume":"11","author":"F Jiang","year":"2015","unstructured":"Jiang\u00a0F, Torgerson\u00a0TR, Ayars\u00a0AG (2015) Health-related quality of life in patients with primary immunodeficiency disease. Allergy Asthma Clin Immunol 11:27","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05331-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05331-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05331-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T07:03:18Z","timestamp":1720076598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05331-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5331"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05331-w","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"7 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>K.\u00a0Giehl<\/b>: A.\u00a0Finanzielle Interessen: K.\u00a0Giehl gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin Klinik f\u00fcr Dermatologie und Allergologie, LMU, M\u00fcnchen | Vorstand Deutsche Stiftung Kinderdermatologie | Mitgliedschaft: DDG. <b>L.\u00a0Frommherz<\/b>: A.\u00a0Finanzielle Interessen: L.\u00a0Frommherz gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Fach\u00e4rztin f\u00fcr Dermatologie, Klinik f\u00fcr Dermatologie und Allergologie, LMU, M\u00fcnchen | Mitgliedschaften: Deutsche Dermatologische Gesellschaft (DDG), Arbeitsgemeinschaft P\u00e4diatrische Dermatologie, European Society of Pediatric Dermatology (ESPD), European Academy of Dermatology and Venereology (EADV), Deutsche Gesellschaft f\u00fcr \u00e4sthetische Botulinum- und Fillertherapie e.\u202fV. (DGBT). <b>F.\u00a0Hauck<\/b>: A.\u00a0Finanzielle Interessen: F.\u00a0Hauck gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Abteilungsleiter P\u00e4diatrische Immunologie und Rheumatologie, Dr. von Haunersches Kinderspital, LMU, M\u00fcnchen | Sprecher Arbeitskreis Klinische Immunologie (AKKI) der Deutschen Gesellschaft f\u00fcr Immunologie (DGFI), Stv. Vorsitzender Arbeitskreis P\u00e4diatrische Immunologie (API). <b>L.\u00a0Ak\u00e7etin<\/b>: A.\u00a0Finanzielle Interessen: L. Ak\u00e7etin gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Assistenz\u00e4rztin f\u00fcr Dermatologie an der Klinik f\u00fcr Dermatologie und Allergologie, LMU, M\u00fcnchen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}